OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
4
Results
Show all
Save search
Copy query
Show results for
Unknown
(4)
Publication Date
Release Date
2022
(2)
2021
(1)
2018
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial.
Not available
S-EPMC9639796
|
biostudies-literature
Cite
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.
Not available
S-EPMC8849184
|
biostudies-literature
Cite
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
Not available
S-EPMC8220996
|
biostudies-literature
Cite
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Not available
S-EPMC5819601
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets